Cargando…
MicroRNAs in sputum specimen as noninvasive biomarkers for the diagnosis of nonsmall cell lung cancer: An updated meta-analysis
BACKGROUND: Nonsmall cell lung cancer (NSCLC) is a serious leading cause of death worldwide. Recently, multiple researches have identified that microRNA (miRNA) in sputum could be a useful tool for NSCLC diagnosis. The objective of this study was to assess whether aberrant miRNA expression could be...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380860/ https://www.ncbi.nlm.nih.gov/pubmed/30732158 http://dx.doi.org/10.1097/MD.0000000000014337 |
_version_ | 1783396379899461632 |
---|---|
author | Zhang, Xiaoyun Wang, Qian Zhang, Shijie |
author_facet | Zhang, Xiaoyun Wang, Qian Zhang, Shijie |
author_sort | Zhang, Xiaoyun |
collection | PubMed |
description | BACKGROUND: Nonsmall cell lung cancer (NSCLC) is a serious leading cause of death worldwide. Recently, multiple researches have identified that microRNA (miRNA) in sputum could be a useful tool for NSCLC diagnosis. The objective of this study was to assess whether aberrant miRNA expression could be regarded as a useful biomarker in sputum specimen for the diagnosis of NSCLC. METHODS: Eligible studies were searched in PubMed, Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang, and VIP databases up to June 2018. We calculated the pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and area under the curve (AUC) to investigate the diagnostic value of miRNA in sputum for NSCLC. MetaDisc1.4 and STATA12.0 were used to analyze the retrieved data. RESULTS: Finally, a total of 14 articles were included in this meta-analysis involving 1009 NSCLC patients and 1006 controls. The results were as followed: the pooled sensitivity, specificity, PLR, NLR, DOR, were 0.75 (95%CI:0.72–0.78), 0.88 (95%CI:0.86–0.90), 5.70 (95%CI:4.82–6.75), 0.30 (95%CI:0.26–0.34), 22.43 (95%CI:17.48–28.79), respectively. The AUC of overall summary receiver operator characteristic curve (SROC) was 0.8917. CONCLUSION: Our comprehensive analysis indicated that miRNAs in sputum specimen may be noninvasive diagnostic biomarkers for NSCLC. However, much more studies should be conducted before clinical application. |
format | Online Article Text |
id | pubmed-6380860 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-63808602019-03-11 MicroRNAs in sputum specimen as noninvasive biomarkers for the diagnosis of nonsmall cell lung cancer: An updated meta-analysis Zhang, Xiaoyun Wang, Qian Zhang, Shijie Medicine (Baltimore) Research Article BACKGROUND: Nonsmall cell lung cancer (NSCLC) is a serious leading cause of death worldwide. Recently, multiple researches have identified that microRNA (miRNA) in sputum could be a useful tool for NSCLC diagnosis. The objective of this study was to assess whether aberrant miRNA expression could be regarded as a useful biomarker in sputum specimen for the diagnosis of NSCLC. METHODS: Eligible studies were searched in PubMed, Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang, and VIP databases up to June 2018. We calculated the pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and area under the curve (AUC) to investigate the diagnostic value of miRNA in sputum for NSCLC. MetaDisc1.4 and STATA12.0 were used to analyze the retrieved data. RESULTS: Finally, a total of 14 articles were included in this meta-analysis involving 1009 NSCLC patients and 1006 controls. The results were as followed: the pooled sensitivity, specificity, PLR, NLR, DOR, were 0.75 (95%CI:0.72–0.78), 0.88 (95%CI:0.86–0.90), 5.70 (95%CI:4.82–6.75), 0.30 (95%CI:0.26–0.34), 22.43 (95%CI:17.48–28.79), respectively. The AUC of overall summary receiver operator characteristic curve (SROC) was 0.8917. CONCLUSION: Our comprehensive analysis indicated that miRNAs in sputum specimen may be noninvasive diagnostic biomarkers for NSCLC. However, much more studies should be conducted before clinical application. Wolters Kluwer Health 2019-02-08 /pmc/articles/PMC6380860/ /pubmed/30732158 http://dx.doi.org/10.1097/MD.0000000000014337 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
spellingShingle | Research Article Zhang, Xiaoyun Wang, Qian Zhang, Shijie MicroRNAs in sputum specimen as noninvasive biomarkers for the diagnosis of nonsmall cell lung cancer: An updated meta-analysis |
title | MicroRNAs in sputum specimen as noninvasive biomarkers for the diagnosis of nonsmall cell lung cancer: An updated meta-analysis |
title_full | MicroRNAs in sputum specimen as noninvasive biomarkers for the diagnosis of nonsmall cell lung cancer: An updated meta-analysis |
title_fullStr | MicroRNAs in sputum specimen as noninvasive biomarkers for the diagnosis of nonsmall cell lung cancer: An updated meta-analysis |
title_full_unstemmed | MicroRNAs in sputum specimen as noninvasive biomarkers for the diagnosis of nonsmall cell lung cancer: An updated meta-analysis |
title_short | MicroRNAs in sputum specimen as noninvasive biomarkers for the diagnosis of nonsmall cell lung cancer: An updated meta-analysis |
title_sort | micrornas in sputum specimen as noninvasive biomarkers for the diagnosis of nonsmall cell lung cancer: an updated meta-analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380860/ https://www.ncbi.nlm.nih.gov/pubmed/30732158 http://dx.doi.org/10.1097/MD.0000000000014337 |
work_keys_str_mv | AT zhangxiaoyun micrornasinsputumspecimenasnoninvasivebiomarkersforthediagnosisofnonsmallcelllungcanceranupdatedmetaanalysis AT wangqian micrornasinsputumspecimenasnoninvasivebiomarkersforthediagnosisofnonsmallcelllungcanceranupdatedmetaanalysis AT zhangshijie micrornasinsputumspecimenasnoninvasivebiomarkersforthediagnosisofnonsmallcelllungcanceranupdatedmetaanalysis |